{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"Research Square"}],"indexed":{"date-parts":[[2024,1,26]],"date-time":"2024-01-26T19:38:05Z","timestamp":1706297885996},"posted":{"date-parts":[[2023,9,5]]},"group-title":"In Review","reference-count":22,"publisher":"Research Square Platform LLC","license":[{"start":{"date-parts":[[2023,9,5]],"date-time":"2023-09-05T00:00:00Z","timestamp":1693872000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2023,8,5]]},"abstract":"<jats:title>Abstract<\/jats:title>\n        <jats:p><jats:bold>Background:<\/jats:bold> The Omicron variant, which main types was BA5.2and BF.7 in China, in December 2022 to January 2023 leaded to off-target of the S and N genes, and the kits used were not adequately and independently evaluated when these agents are studied and developed. To ensure the accuracy of coronavirus test results, performance verification of commercial Real-Time quantitative PCR (RT-qPCR)\nwas required.\n<jats:bold>Objective: <\/jats:bold>We performed a clinical evaluation for two Real Time SARS-CoV-2 assay, and to verify them based on different detection reagents and different clinical specimens.\n<jats:bold>Methods: <\/jats:bold>We performed clinical evaluations of two existing Chinese SARS-CoV-2 RT-qPCR kits COVID-19 nucleic acid detection kits (e-Diagnostic Biomedical, Wuhan, China) and 2019-nCoV nucleic acid diagnostic kits (Fosun Biotechnology, Shanghai, China) using BSD ( Bondson) (Guangzhou Bondson Biotechnology Co. Ltd.;batch number 2022101), quality controls provided by the inspection center and a large number of clinically confirmed specimens.\n<jats:bold>Results:<\/jats:bold> The coincidence rate for Fosun and e-Diagnostic kits were individually 95% and 100%. Verified that the detection limit for Fosun and e-Diagnostic kits was 300copies\/mL. All were below the detection limit for Fosun reagent was 300copies\/mL. e-Diagnostic was 500copies\/mL. Fosun had the largest CV for ORF1ab and N gene at the the detection limit concentration(4.80%,3.49%), while e-Diagnostic had the smaller (0.93%,1.10%). Negative results were tested in cross-reactivity. During the verification of clinical samples, sequencing analyses had shown that Fosun single gene miss rate was relatively high, especially ORF1ab, followed by N gene miss rate. we survey that all N genes were detected in clinical specimens, ,ORFab dropout (i.e., a negative\/low result) occurred in (10.8%) of 225 Omicron variant.\n<jats:bold>Conclusions:<\/jats:bold> Our results endorse the use of these two commercial kits for the diagnosis of SARS-CoV-2 in China, as their clinical performance has been fully validated by a large number of clinically confirmed cases.<\/jats:p>","DOI":"10.21203\/rs.3.rs-3236589\/v1","type":"posted-content","created":{"date-parts":[[2023,9,5]],"date-time":"2023-09-05T15:31:37Z","timestamp":1693927897000},"source":"Crossref","is-referenced-by-count":0,"title":["Application of Metagenomic Next-Generation Sequencing (mNGS) and real-time RT-PCR Using different nasopharyngeal swabs in Diagnosing SARS-CoV-2 Omicron"],"prefix":"10.21203","author":[{"given":"Sujuan","family":"LI","sequence":"first","affiliation":[{"name":"Hangzhou TCM Hospital Affiliated to Zhejiang Chinese Medicine University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuanhang","family":"Zhang","sequence":"additional","affiliation":[{"name":"Hangzhou TCM Hospital Affiliated to Zhejiang Chinese Medicine University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"pengcheng","family":"Tong","sequence":"additional","affiliation":[{"name":"Hangzhou TCM Hospital Affiliated to Zhejiang Chinese Medicine University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"wei","family":"Yang","sequence":"additional","affiliation":[{"name":"Hangzhou TCM Hospital Affiliated to Zhejiang Chinese Medicine University"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"8761","reference":[{"issue":"10317","key":"ref1","doi-asserted-by":"crossref","DOI":"10.1016\/S0140-6736(21)02758-6","article-title":"Omicron SARS-CoV-2 variant: a new chapter in the COVID-19 pandemic","volume":"398","author":"Karim S","year":"2021","unstructured":"Karim S, Karim QA. Omicron SARS-CoV-2 variant: a new chapter in the COVID-19 pandemic. The Lancet, 2021. 398(10317).","journal-title":"The Lancet"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"153171","DOI":"10.1016\/j.scitotenv.2022.153171","article-title":"Detection of the Omicron (B.1.1.529) variant of SARS-CoV-2 in aircraft wastewater","volume":"820","author":"Ahmed W","year":"2022","unstructured":"Ahmed W, et al. Detection of the Omicron (B.1.1.529) variant of SARS-CoV-2 in aircraft wastewater. Sci Total Environ. 2022;820:153171.","journal-title":"Sci Total Environ"},{"key":"ref3","article-title":"Analytical and Clinical Evaluation of Two RT-qPCR SARS-CoV-2 Diagnostic Tests with Emergency Use Authorization in Ecuador","author":"Freire-Paspuel B","unstructured":"Freire-Paspuel B et al. Analytical and Clinical Evaluation of Two RT-qPCR SARS-CoV-2 Diagnostic Tests with Emergency Use Authorization in Ecuador. Am J Trop Med Hyg, 2021(5).","journal-title":"Am J Trop Med Hyg"},{"key":"ref4","author":"Wintersdorff CJHV","unstructured":"Wintersdorff CJHV et al. Infections with the SARS-CoV-2 Delta variant exhibit fourfold increased viral loads in the upper airways compared to Alpha or non-variants of concern. Scientific Reports."},{"issue":"4","key":"ref5","doi-asserted-by":"crossref","DOI":"10.4269\/ajtmh.20-1484","article-title":"Clinical Performance and Analytical Sensitivity of Three SARS-CoV-2 Nucleic Acid Diagnostic Tests","volume":"104","author":"Freire-Paspuel B","year":"2021","unstructured":"Freire-Paspuel B, Garcia-Bereguiain MA. Clinical Performance and Analytical Sensitivity of Three SARS-CoV-2 Nucleic Acid Diagnostic Tests. Am J Trop Med Hyg, 2021. 104(4).","journal-title":"Am J Trop Med Hyg"},{"issue":"12","key":"ref6","first-page":"2492","article-title":"SARS-CoV-2 and Variant Diagnostic Testing Approaches in the United States","volume":"13","author":"Andrews DM","unstructured":"Andrews DM. SARS-CoV-2 and Variant Diagnostic Testing Approaches in the United States. Viruses 13(12): p. 2492.","journal-title":"Viruses"},{"key":"ref7","volume-title":"Analytical sensitivity and efficiency comparisons of SARS-COV-2 qRT-PCR primer-probe sets","author":"Vogels C","year":"2020","unstructured":"Vogels C, et al. Analytical sensitivity and efficiency comparisons of SARS-COV-2 qRT-PCR primer-probe sets. Cold Spring Harbor Laboratory Press; 2020."},{"key":"ref8","author":"Mei YA","year":"2021","unstructured":"Mei YA et al. Performance Verification of Five Commercial RT-qPCR Diagnostic Kits for SARS-CoV-2. 2021."},{"key":"ref9","author":"!!!","unstructured":"!!!. INVALID CITATION !!! [1, 7\u20139]."},{"issue":"3","key":"ref10","doi-asserted-by":"crossref","first-page":"394","DOI":"10.3390\/v13030394","article-title":"The Mutation Profile of SARS-CoV-2 Is Primarily Shaped by the Host Antiviral Defense","volume":"13","author":"Azgari C","year":"2021","unstructured":"Azgari C, et al. The Mutation Profile of SARS-CoV-2 Is Primarily Shaped by the Host Antiviral Defense. Viruses. 2021;13(3):394.","journal-title":"Viruses"},{"key":"ref11","volume-title":"Comparison of Automated SARS-CoV-2 Antigen Test for COVID-19 Infection with Quantitative RT-PCR using 313 Nasopharyngeal Swabs Including from 7 Serially Followed Patients","author":"Hirotsu Y","year":"2020","unstructured":"Hirotsu Y, et al. Comparison of Automated SARS-CoV-2 Antigen Test for COVID-19 Infection with Quantitative RT-PCR using 313 Nasopharyngeal Swabs Including from 7 Serially Followed Patients. International Journal of Infectious Diseases; 2020."},{"key":"ref12","doi-asserted-by":"crossref","DOI":"10.1016\/S0140-6736(21)00370-6","article-title":"SARS-CoV-2 variants and ending the COVID-19 pandemic","author":"Fontanet A","year":"2021","unstructured":"Fontanet A et al. SARS-CoV-2 variants and ending the COVID-19 pandemic. The Lancet, 2021.","journal-title":"The Lancet"},{"key":"ref13","first-page":"1","article-title":"SARS-CoV-2 variants, spike mutations and immune escape","author":"Harvey WT","year":"2021","unstructured":"Harvey WT et al. SARS-CoV-2 variants, spike mutations and immune escape. Nat Rev Microbiol, 2021: p. 1\u201316.","journal-title":"Nat Rev Microbiol"},{"key":"ref14","volume-title":"Is the mRNA COVID-19 Vaccine Safe in Patients With a Prior History of Myocarditis?","author":"Shahid R","year":"2022","unstructured":"Shahid R, et al. Is the mRNA COVID-19 Vaccine Safe in Patients With a Prior History of Myocarditis? Journal of cardiac failure; 2022."},{"issue":"4","key":"ref15","doi-asserted-by":"crossref","first-page":"e0237421","DOI":"10.1128\/jcm.02374-21","article-title":"Impact of SARS-CoV-2 Variants on the Analytical Sensitivity of RT-qPCR Assays","volume":"60","author":"Chen Y","year":"2022","unstructured":"Chen Y, et al. Impact of SARS-CoV-2 Variants on the Analytical Sensitivity of RT-qPCR Assays. J Clin Microbiol. 2022;60(4):e0237421.","journal-title":"J Clin Microbiol"},{"issue":"2","key":"ref16","doi-asserted-by":"crossref","first-page":"242","DOI":"10.3855\/jidc.14972","article-title":"A straightforward molecular strategy to retrospectively investigate the spread of SARS-CoV-2 VOC202012\/01 B.1.1.7 variant","volume":"15","author":"Ibba G","unstructured":"Ibba G et al. A straightforward molecular strategy to retrospectively investigate the spread of SARS-CoV-2 VOC202012\/01 B.1.1.7 variant. J Infect developing Ctries 15(2): p. 242\u20136.","journal-title":"J Infect developing Ctries"},{"issue":"001","key":"ref17","first-page":"010","article-title":"Omicron variant (B.1.1.529) of SARS-CoV-2: Mutation, infectivity, transmission, and vaccine resistance","author":"Ren SY","year":"2022","unstructured":"Ren SY et al. Omicron variant (B.1.1.529) of SARS-CoV-2: Mutation, infectivity, transmission, and vaccine resistance. \u00e4\u00b8\u0096\u00e7\u0095\u008c\u00e4\u00b8\u00b4\u00e5\u00ba\u008a\u00e7\u0097 \u00e4\u00be\u008b\u00e6\u009d\u0082\u00e5\u00bf\u0097, 2022(001): p. 010.","journal-title":"\u00e4\u00b8\u0096\u00e7\u0095\u008c\u00e4\u00b8\u00b4\u00e5\u00ba\u008a\u00e7\u0097 \u00e4\u00be\u008b\u00e6\u009d\u0082\u00e5\u00bf\u0097"},{"key":"ref18","author":"Yu J","year":"2021","unstructured":"Yu J et al. Establishment of reference sequence of SARS-CoV\u20102 and variation analysis based on GISAID clade. 2021."},{"issue":"13","key":"ref19","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00647-20","article-title":"The Nucleocapsid Protein of SARS\u2013CoV-2: a Target for Vaccine Development","volume":"94","author":"Dutta NK","year":"2020","unstructured":"Dutta NK, Mazumdar K, Gordy JT. The Nucleocapsid Protein of SARS\u2013CoV-2: a Target for Vaccine Development. J Virol, 2020. 94(13).","journal-title":"J Virol"},{"issue":"04","key":"ref20","first-page":"6","article-title":"Fear can be more harmful than the severe acute respiratory syndrome coronavirus 2 in controlling the corona virus disease 2019 epidemic","volume":"8","author":"Shi-Yan","year":"2020","unstructured":"Shi-Yan, et al. Fear can be more harmful than the severe acute respiratory syndrome coronavirus 2 in controlling the corona virus disease 2019 epidemic. World J Clin Cases. 2020;8(04):6\u201311.","journal-title":"World J Clin Cases"},{"key":"ref21","author":"Keeney AJ","unstructured":"Keeney AJ et al. Beyond COVID-19: what's next for skill assessment practices in social work education?."},{"key":"ref22","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.puhe.2020.05.056","article-title":"COVID-19 experience reports: An emerging trend in scholarly communication","volume":"185","author":"Kaliya-Perumal AK","year":"2020","unstructured":"Kaliya-Perumal AK, Kharlukhi J, Omar UF. COVID-19 experience reports: An emerging trend in scholarly communication. Public Health. 2020;185:49\u201350.","journal-title":"Public Health"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/www.researchsquare.com\/article\/rs-3236589\/v1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.researchsquare.com\/article\/rs-3236589\/v1.html","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,26]],"date-time":"2024-01-26T18:30:09Z","timestamp":1706293809000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.researchsquare.com\/article\/rs-3236589\/v1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,5]]},"references-count":22,"URL":"https:\/\/doi.org\/10.21203\/rs.3.rs-3236589\/v1","relation":{},"subject":[],"published":{"date-parts":[[2023,9,5]]},"subtype":"preprint"}}